Antiseptic in Japan linked to fewer respiratory symptoms — News-Medical - UA.NEWS
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
In Japan, a 72-day randomized study involving 568 people linked an experimental hand antiseptic to a lower cumulative incidence of upper respiratory symptoms than a commercial ethanol-based product. News-Medical reports on the findings published in the journal Scientific Reports. Trial resultsThe double-blind cluster-randomized study ran from December 20, 2023, to February 29, 2024. Each household was considered a separate cluster. The final analysis included data from 568 participants aged 20 to 65 from 417 households: 285 people were assigned to the experimental formula group and another 283 to the ethanol product group. Participants were required to use one of the two antiseptics five to ten times a day and record daily data on product use and their health status. The experimental formula contained 62% ethanol, 0.05% benzalkonium chloride, and lactic acid. The commercial comparison product contained 79.7% ethanol. Upper respiratory symptoms were recorded in 35 people in the new formula group and 58 in the ethanol antiseptic group. The cumulative incidence was 12.3% versus 20.5%, respectively, meaning it was approximately 40% lower in the first group.
This article is an excerpt. To read the full content, visit the original source. UA.NEWS
Related articles
Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress
Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.
Wearing headphones during surgery may reduce nausea and vomiting afterward - Medical Xpress
Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.
Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily
“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.
0 comments
No comments yet. Be the first to share your thoughts!